Methods of treatment using CTLA-4 antibodies
US8142778B2 · kind B2 · utility
19Cited by
74References
75Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 7, 2008 |
| Grant date | Mar 27, 2012 |
| Priority date | — |
| Expiry date | May 7, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/55516
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides method of treatment using human sequence antibodies against human CTLA-4 linked to a cytotoxic agent. In particular, methods of treating cancer and autoimmune disease are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.